ONC.TSX
Oncolytics Biotech, Inc.

355
Mkt Cap
$86.62M
Volume
638,598.00
52W High
$1.51
52W Low
$0.3258
PE Ratio
-3.02
ONC.TSX Fundamentals
Price
$0.8488
Prev Close
$0.805
Open
$0.81
50D MA
$0.9961
Beta
0.89
Avg. Volume
1.97M
P/B
1,061.00
Loading...
Loading...

About

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oncolytics Biotech, Inc.?
What is the 52-week high for Oncolytics Biotech, Inc.?
What is the 52-week low for Oncolytics Biotech, Inc.?
What is Oncolytics Biotech, Inc. stock price today?
What was Oncolytics Biotech, Inc. stock price yesterday?
What is the PE ratio of Oncolytics Biotech, Inc.?
What is the Price-to-Book ratio of Oncolytics Biotech, Inc.?
What is the 50-day moving average of Oncolytics Biotech, Inc.?

Latest ONC.TSX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.